Experience
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Novartis Pharmaceuticals Corporation et al.
Fresenius Kabi USA, LLC et al.
Trial counsel for Novartis in district court litigation against multiple generics related to KISQALI ®, a blockbuster, breakthrough CDK4/6-inhibitor for the treatment of breast cancer. After a bench trial, the case resulted in a favorable settlement for our client, supporting patent protection at least until 2031.
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al., 1:21-cv-00870, D. Del., Judge Hall
Related Professionals
- Megan L. Meyers
- Associate
- Atlanta, GA
- +1 404 653 6565
- Kathryn R. Judson
- Associate
- Atlanta, GA
- +1 404 653 6466
- Shannon M. Patrick
- Associate
- Atlanta, GA
- +1 404 653 6558
- Candace C. Walther
- Associate
- Atlanta, GA
- +1 404 653 6478